This article breaks down the evolution of the Hospital Price Transparency Rule. This resource highlights new compliance obligations and offers insights into emerging enforcement trends that hospitals should be tracking closely.
It’s not every day your company gets a letter from the government demanding documents, data, and sworn answers under tight deadlines.
Your response, thus, must be swift, strategic, and legally sound. Here’s a practical guide to navigating Civil Investigative Demands.
As Trump seeks to raise U.S. tariffs (which currently tend to be among the lowest worldwide), manufacturers, distributors, retailers, and other companies that frequently import (“importers”) must determine the best strategy to deal with the resulting uncertainties.
This article discusses 6 steps to manage tariff risks in a trade war.
The focus on tariffs by the Trump administration presents significant risks for frequent importers. This in-depth white paper discusses strategies for managing risks during a trade war.
US Attorney General Pam Bondi has renewed the prior Trump administration’s prohibition on the use of sub-regulatory guidance, potentially altering the landscape for False Claims Act cases pursued during the second Trump administration.
The provision of patient assistance, including transportation and other free or discounted items and services to patients by health care providers and suppliers implicate certain fraud and abuse laws.
These law include the prohibition on beneficiary inducements under the federal Civil Monetary Penalties (“CMP”) Law and the federal Anti-Kickback Statute (“AKS”).
This article provides a summary of the CMP Law and AKS and certain exceptions under those laws.